Skip to main content
An official website of the United States government

oregovomab

A murine monoclonal antibody that attaches to the tumor-associated antigen CA125. Vaccination with monoclonal antibody B43.13 may stimulate a host cytotoxic immune response against tumor cells that express CA125.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:B43.13
monoclonal antibody B43.13
OvaRex monoclonal antibody B43.13
US brand name:OvaRex
Abbreviation:MOAB B43.13
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search